FDA Issues Safety Communication For Pain Pump Medications

December 9, 2018

On November 14, 2018, the FDA issued a safety communication in which it warned that patients undergoing treatment or management of pain who are given pain medicines in the spinal fluid (intrathecal administration) that are not FDA approved for use with the implanted pump may be subjected to addition[...]

Continue Reading